Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China
· Delayed Price · Currency is CNY 18.10
+0.09 (0.50%)
Mar 10, 2026, 11:29 AM CST
SHA:605369 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 3,964 | 4,390 | 6,286 | 11,895 | 16,136 | 4,620 | Upgrade
|
| Market Cap Growth | -15.09% | -30.17% | -47.15% | -26.28% | 249.25% | - | Upgrade
|
| Enterprise Value | 3,569 | 3,978 | 5,789 | 11,150 | 15,414 | 3,881 | Upgrade
|
| Last Close Price | 18.01 | 19.76 | 27.57 | 51.42 | 68.89 | 19.40 | Upgrade
|
| PE Ratio | 38.47 | 25.58 | 57.61 | 36.48 | 51.89 | 20.45 | Upgrade
|
| Forward PE | 29.56 | 11.28 | 11.28 | 25.25 | - | - | Upgrade
|
| PS Ratio | 3.53 | 3.94 | 6.45 | 8.10 | 13.51 | 5.57 | Upgrade
|
| PB Ratio | 2.29 | 2.56 | 3.84 | 7.47 | 11.63 | 3.83 | Upgrade
|
| P/TBV Ratio | 2.90 | 3.25 | 4.71 | 7.86 | 12.35 | 4.10 | Upgrade
|
| P/FCF Ratio | 38.15 | 43.56 | 98.89 | 107.58 | 165.62 | 34.58 | Upgrade
|
| P/OCF Ratio | 18.54 | 20.87 | 33.91 | 42.07 | 43.26 | 19.08 | Upgrade
|
| EV/Sales Ratio | 3.17 | 3.57 | 5.94 | 7.59 | 12.91 | 4.68 | Upgrade
|
| EV/EBITDA Ratio | 17.99 | 16.82 | 29.92 | 30.56 | 43.11 | 13.46 | Upgrade
|
| EV/EBIT Ratio | 33.48 | 25.80 | 52.87 | 34.39 | 45.87 | 14.40 | Upgrade
|
| EV/FCF Ratio | 34.35 | 39.48 | 91.06 | 100.84 | 158.21 | 29.05 | Upgrade
|
| Debt / Equity Ratio | 0.11 | 0.03 | 0.02 | 0 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.95 | 0.21 | 0.18 | 0.00 | 0.00 | - | Upgrade
|
| Debt / FCF Ratio | 1.81 | 0.52 | 0.56 | 0.00 | 0.01 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.23 | -0.25 | -0.47 | -0.58 | -0.67 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.20 | -1.66 | -2.13 | -2.06 | -2.26 | -2.82 | Upgrade
|
| Net Debt / FCF Ratio | -3.97 | -3.89 | -6.48 | -6.81 | -8.29 | -6.09 | Upgrade
|
| Asset Turnover | 0.55 | 0.58 | 0.52 | 0.83 | 0.78 | 0.87 | Upgrade
|
| Inventory Turnover | 6.03 | 5.58 | 5.37 | 7.59 | 7.36 | 7.95 | Upgrade
|
| Quick Ratio | 2.59 | 3.88 | 3.60 | 3.82 | 3.48 | 5.97 | Upgrade
|
| Current Ratio | 3.08 | 4.73 | 4.31 | 4.31 | 3.89 | 6.41 | Upgrade
|
| Return on Equity (ROE) | 5.98% | 10.22% | 6.75% | 21.88% | 23.96% | 28.00% | Upgrade
|
| Return on Assets (ROA) | 3.24% | 5.03% | 3.65% | 11.39% | 13.70% | 17.62% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.44% | 10.98% | 9.70% | 40.17% | 59.36% | 67.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.00% | 8.70% | 6.50% | 20.20% | 24.00% | 22.20% | Upgrade
|
| Earnings Yield | 2.58% | 3.91% | 1.74% | 2.74% | 1.93% | 4.89% | Upgrade
|
| FCF Yield | 2.62% | 2.30% | 1.01% | 0.93% | 0.60% | 2.89% | Upgrade
|
| Dividend Yield | 3.15% | 2.53% | 1.48% | 0.30% | 1.02% | 3.38% | Upgrade
|
| Payout Ratio | 109.66% | 47.33% | 82.56% | 47.67% | 46.30% | - | Upgrade
|
| Buyback Yield / Dilution | 1.50% | 0.43% | -0.82% | 0.20% | -23.76% | -7.82% | Upgrade
|
| Total Shareholder Return | 4.65% | 2.96% | 0.66% | 0.50% | -22.73% | -4.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.